Skip to content

Granusept

by CF Pharma Ireland Ltd EUDAMED

Active European Union

Ref FP1648, FP1650, FP1646, FP1647, FP1649Model Granusept MD 60ml Gel Polish language, Granusept MD 500ml Liquid Polish language, Granusept MD 150ml Liquid Polish language, Granusept MD 150ml Gel Polish language, Granusept MD 1000ml Liquid Polish language

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-05907377532514 Basic UDI-DIDate5 Apr 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Model / Reference
Granusept MD 60ml Gel Polish language, FP1648, Granusept MD 500ml Liquid Polish language, FP1650, Granusept MD 150ml Liquid Polish language, FP1646, Granusept MD 150ml Gel Polish language, FP1647, Granusept MD 1000ml Liquid Polish language, FP1649
Primary DI / UDI-DI
05907377532514, 05907377532446, 05907377532538, 05907377532453, 05907377532507
Basic UDI-DI
B-05907377532514, B-05907377532446, B-05907377532538, B-05907377532453, B-05907377532507
EMDN Code
V9099 Various devices not included in other classes - other
Device Class
Class IIa
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
IE-MF-000004595

Other devices from CF Pharma Ireland Ltd

See all devices from CF Pharma Ireland Ltd →

Properties

Other properties (11)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No